{"entity":{"type":"insider","cik":"0001711462","url":"/insider/0001711462","json_url":"/insider/0001711462.json","name":"Lizzul Paul F.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2017-08-01","last":"2026-01-09","span_basis":"filed_date"},"name_variants":[{"name":"Lizzul Paul F.","source":"filing","n_filings":11,"first_seen":"2017-08-01","last_seen":"2026-01-09"}],"transactions":[{"id":6003703,"accession":"0001711462-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001711462-26-000006","line_url":"/filing/0001711462-26-000006#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3650.0,"shares_display":"3,650","price_per_share":44.71,"price_display":"44.71","price_state":"stated","total_value":163191.5,"total_display":"163,191.50","total_whole":"163,192","shares_owned_after":42088.0,"shares_owned_after_display":"42,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-08","filed_date":"2026-01-09","scope":"insider"},{"id":5949190,"accession":"0001711462-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001711462-26-000004","line_url":"/filing/0001711462-26-000004#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2235.0,"shares_display":"2,235","price_per_share":45.11,"price_display":"45.11","price_state":"stated","total_value":100820.85,"total_display":"100,820.85","total_whole":"100,821","shares_owned_after":37213.0,"shares_owned_after_display":"37,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-07","filed_date":"2026-01-08","scope":"insider"},{"id":6045890,"accession":"0001711462-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001711462-26-000002","line_url":"/filing/0001711462-26-000002#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4219.0,"shares_display":"4,219","price_per_share":43.26,"price_display":"43.26","price_state":"stated","total_value":182513.94,"total_display":"182,513.94","total_whole":"182,514","shares_owned_after":33303.0,"shares_owned_after_display":"33,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":4999566,"accession":"0001711462-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001711462-25-000003","line_url":"/filing/0001711462-25-000003#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":26967.0,"shares_owned_after_display":"26,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-23","scope":"insider"},{"id":2044135,"accession":"0001415889-24-023900","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023900","line_url":"/filing/0001415889-24-023900#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":38.67,"price_display":"38.67","price_state":"stated","total_value":58005.0,"total_display":"58,005.00","total_whole":"58,005","shares_owned_after":15398.0,"shares_owned_after_display":"15,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-23","filed_date":"2024-09-24","scope":"insider"},{"id":3054941,"accession":"0001415889-24-023550","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023550","line_url":"/filing/0001415889-24-023550#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2220.0,"shares_display":"2,220","price_per_share":38.93,"price_display":"38.93","price_state":"stated","total_value":86424.6,"total_display":"86,424.60","total_whole":"86,425","shares_owned_after":15398.0,"shares_owned_after_display":"15,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":2900350,"accession":"0001415889-24-021452","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-021452","line_url":"/filing/0001415889-24-021452#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":11618.0,"shares_owned_after_display":"11,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-16","scope":"insider"},{"id":3262997,"accession":"0001415889-24-019829","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019829","line_url":"/filing/0001415889-24-019829#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":52500.0,"total_display":"52,500.00","total_whole":"52,500","shares_owned_after":11618.0,"shares_owned_after_display":"11,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-18","filed_date":"2024-07-19","scope":"insider"},{"id":2640503,"accession":"0001209191-24-001280","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001280","line_url":"/filing/0001209191-24-001280#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2554.0,"shares_display":"2,554","price_per_share":21.81,"price_display":"21.81","price_state":"stated","total_value":55702.74,"total_display":"55,702.74","total_whole":"55,703","shares_owned_after":10118.0,"shares_owned_after_display":"10,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":8753383,"accession":"0001209191-23-049810","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-049810","line_url":"/filing/0001209191-23-049810#line-2","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2105.0,"shares_display":"2,105","price_per_share":19.48,"price_display":"19.48","price_state":"stated","total_value":41005.4,"total_display":"41,005.40","total_whole":"41,005","shares_owned_after":6527.0,"shares_owned_after_display":"6,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-18","scope":"insider"},{"id":4172750,"accession":"0001140361-17-029595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-029595","line_url":"/filing/0001140361-17-029595#line-2","is_derivative":false,"issuer_cik":"0001656328","issuer_name":"Sienna Biopharmaceuticals, Inc.","issuer_ticker":"SNNA","issuer_name_source":null,"issuer_url":"/issuer/0001656328","owner_cik":"0001711462","owner_name":"Lizzul Paul F.","owner_display_name":"Lizzul Paul F.","owner_url":"/insider/0001711462","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":94634.0,"shares_owned_after_display":"94,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-01","filed_date":"2017-08-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO, INC","url":"/issuer/0001370053","role":"Officer (Chief Medical Officer)","n_filings":10,"first_seen":"2023-09-18","last_seen":"2026-01-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001656328","name":"Sienna Biopharmaceuticals, Inc.","url":"/issuer/0001656328","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2017-08-01","last_seen":"2017-08-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001711462","retrieved_at":"2026-08-23T16:53:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}